Boxer Capital LLC 13D and 13G filings for PMV Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:02 pm Sale | 2023-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | Boxer Capital LLC | 0 0.000% | -3,163,795 (Position Closed) | Filing |
| 2023-02-14 1:10 pm Purchase | 2022-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | Boxer Capital LLC | 3,163,795 6.900% | 325,559 (+11.47%) | Filing |
| 2022-02-14 4:16 pm Purchase | 2021-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | Boxer Capital LLC | 2,838,236 6.300% | 570,000 (+25.13%) | Filing |
| 2020-09-30 4:33 pm Purchase | 2020-09-25 | 13G | PMV Pharmaceuticals, Inc. PMVP | Boxer Capital LLC | 2,268,236 5.100% | 2,268,236 (New Position) | Filing |